An international non-interventional prospective cohort study to evaluate the safety of treatment with Levemir® (insulin detemir) in pregnant women with diabetes mellitus.
  • NCT01892319
  • dott.ssa Marina Scavini
  • dott.ssa Amelia Caretto, dott.ssa Alice Burini
  • Observational
  • The overall objective of the Diabetes Pregnancy Registry is to monitor and assess the safety of
    Levemir® use in pregnant women with diabetes mellitus (DM), and to monitor their infants at 1 month and 1 year of age.

  • Type 1 diabetes
  • Screening
  • N/A
  • Single group
  • N/A (not applicable)
  • 15
  • Marina
  • Scavini
  • 0226432419
  • scavini.marina@hsr.it
  • Completed